Zeng ZC - Search Results

1

Mass spectrometry-based serum peptide profiling in hepatocellular carcinoma with bone metastasis.

He J, Zeng ZC, Xiang ZL, Yang P. He J, et al. Among authors: zeng zc. World J Gastroenterol. 2014 Mar 21;20(11):3025-32. doi: 10.3748/wjg.v20.i11.3025. World J Gastroenterol. 2014. PMID: 24659894 Free PMC article.

2

DNA-PKcs subunits in radiosensitization by hyperthermia on hepatocellular carcinoma hepG2 cell line.

Zeng ZC, Jiang GL, Wang GM, Tang ZY, Curran WJ, Iliakis G. Zeng ZC, et al. World J Gastroenterol. 2002 Oct;8(5):797-803. doi: 10.3748/wjg.v8.i5.797. World J Gastroenterol. 2002. PMID: 12378618 Free PMC article.

3

Docetaxel inhibits SMMC-7721 human hepatocellular carcinoma cells growth and induces apoptosis.

Geng CX, Zeng ZC, Wang JY. Geng CX, et al. Among authors: zeng zc. World J Gastroenterol. 2003 Apr;9(4):696-700. doi: 10.3748/wjg.v9.i4.696. World J Gastroenterol. 2003. PMID: 12679913 Free PMC article.

4

Radiation therapy for the locoregional lymph node metastases from hepatocellular carcinoma, phase I clinical trial.

Zeng ZC, Tang ZY, Yang BH, Fan J, Qin LX, Jiang GL, Zhou J, Sun HC, Cheng JM, Wang JH. Zeng ZC, et al. Hepatogastroenterology. 2004 Jan-Feb;51(55):201-7. Hepatogastroenterology. 2004. PMID: 15011864 Clinical Trial.

5

Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma receiving external beam radiotherapy.

He J, Zeng ZC, Tang ZY, Fan J, Zhou J, Zeng MS, Wang JH, Sun J, Chen B, Yang P, Pan BS. He J, et al. Among authors: zeng zc, zeng ms. Cancer. 2009 Jun 15;115(12):2710-20. doi: 10.1002/cncr.24300. Cancer. 2009. PMID: 19382203 Free article.

6

Impact factors for microinvasion in patients with hepatocellular carcinoma: possible application to the definition of clinical tumor volume.

Wang MH, Ji Y, Zeng ZC, Tang ZY, Fan J, Zhou J, Zeng MS, Bi AH, Tan YS. Wang MH, et al. Among authors: zeng zc, zeng ms. Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):467-76. doi: 10.1016/j.ijrobp.2009.01.057. Epub 2009 May 4. Int J Radiat Oncol Biol Phys. 2010. PMID: 19406586

7

Chemokine receptor CXCR4 expression in hepatocellular carcinoma patients increases the risk of bone metastases and poor survival.

Xiang ZL, Zeng ZC, Tang ZY, Fan J, Zhuang PY, Liang Y, Tan YS, He J. Xiang ZL, et al. Among authors: zeng zc. BMC Cancer. 2009 Jun 9;9:176. doi: 10.1186/1471-2407-9-176. BMC Cancer. 2009. PMID: 19508713 Free PMC article.

8

Increased expression of vascular endothelial growth factor-C and nuclear CXCR4 in hepatocellular carcinoma is correlated with lymph node metastasis and poor outcome.

Xiang Z, Zeng Z, Tang Z, Fan J, Sun H, Wu W, Tan Y. Xiang Z, et al. Cancer J. 2009 Nov-Dec;15(6):519-25. doi: 10.1097/PPO.0b013e3181c6aa6b. Cancer J. 2009. PMID: 20010172

9

[Nuclear accumulation of CXCR4 and overexpressions of VEGF-C and CK19 are associated with a higher risk of lymph node metastasis in hepatocellular carcinoma].

Xiang ZL, Zeng ZC, Tang ZY, Fan J, Sun HC, Wu WZ, Tan YS. Xiang ZL, et al. Among authors: zeng zc. Zhonghua Zhong Liu Za Zhi. 2010 May;32(5):344-9. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 20723431 Chinese.

10

Expression of cytokeratin 19 and matrix metalloproteinase 2 predicts lymph node metastasis in hepatocellular carcinoma.

Xiang ZL, Zeng ZC, Tang ZY, Fan J, Sun HC, Tan YS. Xiang ZL, et al. Among authors: zeng zc. Mol Biol Rep. 2011 Jun;38(5):3531-9. doi: 10.1007/s11033-010-0463-x. Epub 2010 Nov 23. Mol Biol Rep. 2011. PMID: 21104440

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

283 results

Search Page

Filters